Lv45
752 积分 2026-02-05 加入
Identification and utility exploration of a highly potent and long-acting bullfrog GLP-1 analogue in GLP-1 and amylin combination therapy
16天前
已完结
Cagrilintide–semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study
21天前
已关闭
Cagrilintide–semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study
21天前
已关闭
Decoding KRAS dynamics: Exploring the impact of mutations and inhibitor binding
22天前
已完结
Identification of Degenerated Murine Facial Nerves With Fluorescence Labeling After Transection Injury
2个月前
已完结
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
2个月前
已完结
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial
2个月前
已完结
Bispecific anti-PD-1/CTLA-4 Antibody for Advanced Solid Tumors
3个月前
已完结
Novel O-methylpyrimidine prodrugs of phenolic compounds bioactivated by aldehyde oxidase: Enhancing metabolic stability against first-pass conjugative metabolism in the intestine
3个月前
已完结
Small nucleic acid therapeutics: delivery breakthroughs, clinical translation, and future paradigms in precision medicine
3个月前
已完结
皖公网安备34019202002308
